AmpliSNiP Diagnostic Kits: Analysis
of Polymorphisms in the Risk of Dementia and Pharmacological Therapy
AmpliSNiP Dementia Screening Panel (qPCR)
Panel diagnostic kit for assessing the risk of developing dementia and the rate of drug metabolism used in alleviating symptoms and/or slowing the progression of the disease, using the DMAS-qPCR technique
AmpliSNiP Dementia Risk Assessment Panel (qPCR)
Panel diagnostic kit for assessing the risk of developing dementia using the DMAS-qPCR technique
AmpliSNiP Dementia Medication Metabolism Panel (qPCR)
Panel diagnostic kit for assessing the rate of drug metabolism used to alleviate symptoms and/or slow down the progression of the disease using the DMAS-qPCR technique